Skip to main content
. 2017 Apr 19;8(27):44073–44081. doi: 10.18632/oncotarget.17237

Table 2. Dose-escalation strategy.

DoseLevel Irinotecan Cisplatin Olaparib Mitomycin C
−1 Irinotecan 70 mg/m2 on days 1 and 8 Cisplatin 25 mg/m2 on days 1 and 8 50mg twice a day on days 1 and 8 None
1 Irinotecan 70 mg/m2 on days 1 and 8 Cisplatin 25 mg/m2 on days 1 and 8 100 mg twice a day on days 1 and 8 None
2 Irinotecan 70 mg/m2 on days 1 and 8 Cisplatin 25 mg/m2 on days 1 and 8 100mg twice a day on days 1–3, 8–10 None
3 Irinotecan 70 mg/m2 on days 1 and 8 Cisplatin 25 mg/m2 on days 1 and 8 200 mg twice a day on days 1–3, 8–10 None
4 Irinotecan 70 mg/m2 on days 1 and 8 Cisplatin 25 mg/m2 on days 1 and 8 200 mg twice a day on days 1–12 None
5 Irinotecan 70 mg/m2 on days 1 and 8 Cisplatin 25 mg/m2 on days 1 and 8 MTD from dose level escalation (−1 to 4) 5 mg/m2 on day 1

Treatment days are in reference to a 28-day treatment cycle